Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
https://www.cnbc.com/2023/12/05/eli-lilly-weight-loss-drug-zepbound-available-at-us-pharmacies.html
Dec 05, 2023 - Eli Lilly's drug serves as an alternative to rival obesity drugs such as Wegovy that are still facing supply issues.
0
Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes
https://www.cnbc.com/2024/02/06/healthy-returns-novo-nordisk-eli-lilly-tackle-weight-loss-drug-supply-woes.html
Feb 06, 2024 - Novo Nordisk and Eli Lilly are working to increase supply of their popular weight loss drugs. Meanwhile, the implantable neurotechnology field is heating up.
0
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
https://www.cnbc.com/2024/02/06/eli-lilly-weight-loss-drug-may-treat-fatty-liver-disease.html
Feb 06, 2024 - The results add to a long list of potential health benefits of tirzepatide besides helping patients shed significant pounds and regulate blood sugar.
0
Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
https://seekingalpha.com/news/4063338-nash-drug-developers-drop-trial-win-lilly-drug?source=feed_sector_healthcare
Feb 06, 2024 - Companies focused on NASH drugs drop as Eli Lilly's (LLY) weight loss drug, tirzepatide, hits main goal in a mid-stage trial for the liver disease. Read more here.
0
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
https://www.cnbc.com/2024/02/10/weight-loss-drugs-novo-nordisk-eli-lilly-are-tackling-supply-issues.html
Feb 10, 2024 - Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.
0
4 stocks to watch on Friday: Plug Power, Eli Lilly and more
https://seekingalpha.com/news/4074559-4-stocks-to-watch-on-friday-plug-power-eli-lilly-and-more?source=feed_sector_healthcare
Mar 01, 2024 - Plug Power (PLUG), Eli Lilly (LLY), Microsoft (MSFT) and Warner Bros. Discovery (WBD) are the stocks to watch on Friday.
0
Eli Lilly said to have tapped National Resilience, BSP for Zepbound production
https://seekingalpha.com/news/4076137-eli-lilly-taps-national-resilience-bsp-make-zepbound?source=feed_sector_healthcare
Mar 05, 2024 - Eli Lilly (LLY) has inked deals with contract manufacturers National Resilience and BSP Pharmaceuticals to produce its weight loss drug Zepbound. Read more here.
0
Eli Lilly Zepbound prescriptions exceed Novo’s Wegovy for the first time in U.S.
https://seekingalpha.com/news/4080150-eli-lilly-zepbound-prescriptions-exceed-novos-wegovy?source=feed_sector_healthcare
Mar 15, 2024 - Eli Lilly's (LLY) weight loss drug Zepbound surpasses Novo Nordisk's (NVO) rival therapy Wegovy in terms of new US prescriptions for the first time. Read more here.
0
2seventy bio appoints Eli Casdin and Charles Newton to its board of directors
https://seekingalpha.com/news/4081841-2seventy-bio-appoints-eli-casdin-and-charles-newton-to-its-board-of-directors?source=feed_sector_healthcare
Mar 20, 2024 - 2seventy bio (TSVT) announces the appointment of Eli Casdin and Charles Newton to its board of directors.
0
Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?
https://www.fool.com/investing/2024/03/28/eli-lilly-vs-berkshire-hathaway-which-stock-will-b/?source=iedfolrf0000001
Mar 28, 2024 - Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first.
0
Page 1>